Director, Regulatory Affairs
Natasha is a Regulatory Affairs professional with over 14 years regulatory experience in drug development and registrations for biological and small molecules, including orphan drugs: clinical development, scientific advice and pre-submission meetings, MAA, paediatric investigation plans and lifecycle management for EU centrally approved products. Natasha’s particular experience lies across the therapeutic areas of oncology and transplant (NCE); immunology, enzyme-replacement therapy (biotechnology), HRT, CNS and cardiovascular.
Qualifying at St Petersburg State Academy of Chemistry and Pharmacy, Natasha worked in Russia for a number of years as Head of Hospital Pharmacy and as a Pharmaceutical Consultant. In 2001, Natasha moved to Regulatory Affairs at AMGEN and from there has held Regulatory positions at PAREXEL International, Transkaryotic Therapies (now Shire), Genzyme and more recently at REGEM Consulting as a Regulatory Consultant.
Natasha, a member of TOPRA, brings her expertise in project management to the team at Boyds. She is a confident communicator with regulatory authorities, clients and project team members.
Unit M, South Cambridge Business Park
Babraham Road, Sawston
CB22 3JH, UK
T +44 (0)1954 252652
F +44 (0)1270 253832
M +44 (0)7471 351155
- +44 (0)1954 252652